Cardiovascular Disease in Glendale, CA
32 verified cardiovascular disease doctors in Glendale.
Cardiologists diagnose and treat conditions of the heart and blood vessels, including heart disease, arrhythmias, and heart failure.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. David Tonnemacher, MD
Cardiovascular Disease
CMS Open Payments· $233.49 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$233.49
Total received
5
Transactions
4
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 54th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to David Tonnemacher do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Haroutioun Mesrobian, MD
Cardiovascular Disease
CMS Open Payments· $2,301 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$2,301
Total received
46
Transactions
13
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 83th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Haroutioun Mesrobian do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Onkarjit Marwah, MD
Cardiovascular Disease
CMS Open Payments· $3,507 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$3,507
Total received
47
Transactions
17
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 86th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Onkarjit Marwah do not imply any wrongdoing. Many are meals, education, or research support.
Dr. John Mckenzie, MD
Cardiovascular Disease
CMS Open Payments· $15,982 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$15,982
Total received
196
Transactions
23
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is higher than 92% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to John Mckenzie do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Hieu Nguyen, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Anthony Anderson, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Edgar Aleman, MD
Cardiovascular Disease
CMS Open Payments· $2,328 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$2,328
Total received
67
Transactions
18
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 83th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Edgar Aleman do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Hugo Riffel Dalinger, MD
Cardiovascular Disease
CMS Open Payments· $19,280 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$19,280
Total received
136
Transactions
23
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is higher than 93% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Hugo Riffel Dalinger do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Razmik Ohanjanian, MD
Cardiovascular Disease
CMS Open Payments· $2,091 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$2,091
Total received
109
Transactions
27
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 82th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Razmik Ohanjanian do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Gerald Pohost, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. James Kulczycki, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Jihad Al Imami, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Amir Hedayati-Rad, MD
Cardiovascular Disease
CMS Open Payments· $782.94 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$782.94
Total received
28
Transactions
6
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 70th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Amir Hedayati-Rad do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Armen Aghabegian, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Harry Balian, MD
Cardiovascular Disease
CMS Open Payments· $8,753 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$8,753
Total received
196
Transactions
27
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is higher than 90% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Harry Balian do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Joseph Bornheimer, MD
Cardiovascular Disease
CMS Open Payments· $93.43 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$93.43
Total received
5
Transactions
3
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is on the lower end — around the 45th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Joseph Bornheimer do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Joseph Lee, MD
Cardiovascular Disease
CMS Open Payments· $3,838 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$3,838
Total received
164
Transactions
27
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 87th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Joseph Lee do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Eric Lee, MD
Cardiovascular Disease
CMS Open Payments· $2,921 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$2,921
Total received
111
Transactions
26
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 85th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Eric Lee do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Vahe Badalian, MD
Cardiovascular Disease
CMS Open Payments· $128.93 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$128.93
Total received
5
Transactions
5
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is on the lower end — around the 47th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Vahe Badalian do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Yung-Hsi Wen, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Lawrence O'Connor, MD
Cardiovascular Disease
CMS Open Payments· $3,251 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$3,251
Total received
146
Transactions
20
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 86th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Lawrence O'Connor do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Yuri Busi, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Michael Stark, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Hossein Dehghani, MD
Cardiovascular Disease
CMS Open Payments· $616.64 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$616.64
Total received
21
Transactions
10
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 66th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Hossein Dehghani do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Sanjay Sharma, MD
Cardiovascular Disease
CMS Open Payments· $6,124 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$6,124
Total received
139
Transactions
20
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 89th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Sanjay Sharma do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Amir Sadrzadeh Rafie, MD
Cardiovascular Disease
CMS Open Payments· $9,670 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$9,670
Total received
222
Transactions
29
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is higher than 90% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Amir Sadrzadeh Rafie do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Sarkis Kiramijyan, MD
Cardiovascular Disease
CMS Open Payments· $2,987 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$2,987
Total received
115
Transactions
28
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 85th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Sarkis Kiramijyan do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Daniel Daneshvar, MD
Cardiovascular Disease
CMS Open Payments· $171.12 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$171.12
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 51th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Daniel Daneshvar do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Hambik Tankazyan, DO
Cardiovascular Disease
CMS Open Payments· $6,101 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$6,101
Total received
92
Transactions
15
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 89th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Hambik Tankazyan do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Santo Polito, MD
Cardiovascular Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Ziad Sayedahmad, MD
Cardiovascular Disease
CMS Open Payments· $1,624 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,624
Total received
46
Transactions
17
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 79th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Ziad Sayedahmad do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Julio Mendez Loreto, MD
Cardiovascular Disease
CMS Open Payments· $146.10 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$146.10
Total received
5
Transactions
2
Paying companies
Top paying companies
Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total is on the lower end — around the 49th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.
Payments to Julio Mendez Loreto do not imply any wrongdoing. Many are meals, education, or research support.